Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 4/2008

01-07-2008 | Original Article

Cigarette smoke-induced pancreatic damage—experimental data

Authors: Uwe A. Wittel, Ulrich T. Hopt, Surinder K. Batra

Published in: Langenbeck's Archives of Surgery | Issue 4/2008

Login to get access

Abstract

Background and aims

Epidemiological data clearly indicate that cigarette smoking is associated with an increased risk for developing chronic pancreatitis and pancreatic cancer. Despite of this clear epidemiological correlation, cigarette smoke-induced pancreatic damage has only been investigated in a small number of experimental studies.

Methods

Experimental studies examining the effect of cigarette smoke or cigarette smoke constituents on the pancreas were reviewed.

Results

Recent data indicate that smoking also induces chronic pancreatic inflammation in rodents within a period of 12 weeks upon exposure with environmental cigarette smoke. Supported by the finding that morphologic pancreatic damage is also induced by nicotine treatment, cigarette smoke-induced pancreatic damage is likely to be caused by a disturbance of regulation of exocrine pancreas. The morphological alterations, however, induced by nicotine, are less pronounced and therefore, other substances and pathophysiologic mechanisms, such as carcinogen action or cigarette smoke-induced reduction of anti-protease activity, are likely to aggravate pancreatic damage upon cigarette smoke inhalation.

Conclusion

These data indicate that several constituents of cigarette smoke induce a disturbance of pancreatic function. This multifactorial event induces morphologic pancreatic damage upon cigarette smoke exposure in rodents.
Literature
1.
go back to reference Weiss W, Benarde MA (1983) The temporal relation between cigarette smoking and pancreatic cancer. Am J Public Health 73:1403–1404PubMed Weiss W, Benarde MA (1983) The temporal relation between cigarette smoking and pancreatic cancer. Am J Public Health 73:1403–1404PubMed
2.
go back to reference Levi F, Lucchini F, Negri E, La VC (2003) Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas 27:139–142PubMedCrossRef Levi F, Lucchini F, Negri E, La VC (2003) Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas 27:139–142PubMedCrossRef
3.
go back to reference Parkin DM, Pisani P, Lopez AD, Masuyer E (1994) At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 59:494–504PubMedCrossRef Parkin DM, Pisani P, Lopez AD, Masuyer E (1994) At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 59:494–504PubMedCrossRef
4.
go back to reference Fernandez E, La VC, Porta M, Negri E, Lucchini F, Levi F (1994) Trends in pancreatic cancer mortality in Europe, 1955–1989. Int J Cancer 57:786–792PubMedCrossRef Fernandez E, La VC, Porta M, Negri E, Lucchini F, Levi F (1994) Trends in pancreatic cancer mortality in Europe, 1955–1989. Int J Cancer 57:786–792PubMedCrossRef
5.
go back to reference Mulder I, Hoogenveen RT, van Genugten ML, Lankisch PG, Lowenfels AB, de Hollander AE, Bueno-de-Mesquita HB (2002) Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol 14:1343–1353PubMedCrossRef Mulder I, Hoogenveen RT, van Genugten ML, Lankisch PG, Lowenfels AB, de Hollander AE, Bueno-de-Mesquita HB (2002) Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol 14:1343–1353PubMedCrossRef
6.
go back to reference Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, Ramadani M, Henne-Bruns D, Beger HG, El-Bayoumy K (2002) Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 15:677–685PubMedCrossRef Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, Ramadani M, Henne-Bruns D, Beger HG, El-Bayoumy K (2002) Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 15:677–685PubMedCrossRef
7.
go back to reference IARC (2004) Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol 83. WHO International Agency for Research on Cancer, Lyon, France IARC (2004) Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol 83. WHO International Agency for Research on Cancer, Lyon, France
8.
go back to reference Rao MS (1987) Animal models of exocrine pancreatic carcinogenesis. Cancer Metastasis Rev 6:665–676PubMedCrossRef Rao MS (1987) Animal models of exocrine pancreatic carcinogenesis. Cancer Metastasis Rev 6:665–676PubMedCrossRef
9.
go back to reference Wei D, Xiong HQ, Abbruzzese JL, Xie K (2003) Experimental animal models of pancreatic carcinogenesis and metastasis. Int J Gastrointest Cancer 33:43–60PubMedCrossRef Wei D, Xiong HQ, Abbruzzese JL, Xie K (2003) Experimental animal models of pancreatic carcinogenesis and metastasis. Int J Gastrointest Cancer 33:43–60PubMedCrossRef
10.
go back to reference Chowdhury P, MacLeod S, Udupa KB, Rayford PL (2002) Pathophysiological effects of nicotine on the pancreas: an update. Exp Biol Med (Maywood) 227:445–454 Chowdhury P, MacLeod S, Udupa KB, Rayford PL (2002) Pathophysiological effects of nicotine on the pancreas: an update. Exp Biol Med (Maywood) 227:445–454
11.
go back to reference Schuller HM (2007) Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res 39:45–63PubMedCrossRef Schuller HM (2007) Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res 39:45–63PubMedCrossRef
12.
go back to reference Hoffmann D, Rivenson A, Abbi R, Wynder EL (1993) A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res 53:2758–2761PubMed Hoffmann D, Rivenson A, Abbi R, Wynder EL (1993) A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res 53:2758–2761PubMed
13.
go back to reference Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 48:6912–6917PubMed Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 48:6912–6917PubMed
14.
go back to reference Standop J, Schneider MB, Ulrich A, Pour PM (2001) Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer. Dig Dis 19:24–31PubMedCrossRef Standop J, Schneider MB, Ulrich A, Pour PM (2001) Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer. Dig Dis 19:24–31PubMedCrossRef
15.
go back to reference Bockman DE, Guo J, Buchler P, Muller MW, Bergmann F, Friess H (2003) Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest 83:853–859PubMed Bockman DE, Guo J, Buchler P, Muller MW, Bergmann F, Friess H (2003) Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest 83:853–859PubMed
16.
go back to reference Chowdhury P, Doi R, Tangoku A, Rayford PL (1995) Structural and functional changes of rat exocrine pancreas exposed to nicotine. Int J Pancreatol 18:257–264PubMed Chowdhury P, Doi R, Tangoku A, Rayford PL (1995) Structural and functional changes of rat exocrine pancreas exposed to nicotine. Int J Pancreatol 18:257–264PubMed
17.
go back to reference van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, van der PT (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130:1822–1830PubMedCrossRef van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, van der PT (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130:1822–1830PubMedCrossRef
18.
go back to reference Chowdhury P, Hosotani R, Rayford PL (1989) Inhibition of CCK or carbachol-stimulated amylase release by nicotine. Life Sci 45:2163–2168PubMedCrossRef Chowdhury P, Hosotani R, Rayford PL (1989) Inhibition of CCK or carbachol-stimulated amylase release by nicotine. Life Sci 45:2163–2168PubMedCrossRef
19.
go back to reference Chowdhury P, Rayford PL, Chang LW (1992) Induction of pancreatic acinar pathology via inhalation of nicotine. Proc Soc Exp Biol Med 201:159–164PubMed Chowdhury P, Rayford PL, Chang LW (1992) Induction of pancreatic acinar pathology via inhalation of nicotine. Proc Soc Exp Biol Med 201:159–164PubMed
20.
go back to reference Chowdhury P, Hosotani R, Chang L, Rayford PL (1990) Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats. Pancreas 5:222–229PubMedCrossRef Chowdhury P, Hosotani R, Chang L, Rayford PL (1990) Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats. Pancreas 5:222–229PubMedCrossRef
21.
go back to reference Wittel UA, Singh AP, Henley BJ, Andrianifahanana M, Akhter MP, Cullen DM, Batra SK (2006) Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. Pancreas 33:364–370PubMedCrossRef Wittel UA, Singh AP, Henley BJ, Andrianifahanana M, Akhter MP, Cullen DM, Batra SK (2006) Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. Pancreas 33:364–370PubMedCrossRef
22.
go back to reference Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, Brand RE, Prokopczyk B, Batra SK (2006) Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 101:148–159PubMedCrossRef Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, Brand RE, Prokopczyk B, Batra SK (2006) Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 101:148–159PubMedCrossRef
23.
go back to reference Shi MM, Chong IW, Long NC, Love JA, Godleski JJ, Paulauskis JD (1998) Functional characterization of recombinant rat macrophage inflammatory protein-1 alpha and mRNA expression in pulmonary inflammation. Inflammation 22:29–43PubMedCrossRef Shi MM, Chong IW, Long NC, Love JA, Godleski JJ, Paulauskis JD (1998) Functional characterization of recombinant rat macrophage inflammatory protein-1 alpha and mRNA expression in pulmonary inflammation. Inflammation 22:29–43PubMedCrossRef
24.
go back to reference Rau B, Paszkowski A, Lillich S, Baumgart K, Moller P, Beger HG (2001) Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest 81:1001–1013PubMed Rau B, Paszkowski A, Lillich S, Baumgart K, Moller P, Beger HG (2001) Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest 81:1001–1013PubMed
25.
go back to reference Rane SG, Lee JH, Lin HM (2006) Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. Cytokine Growth Factor Rev 17:107–119PubMedCrossRef Rane SG, Lee JH, Lin HM (2006) Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. Cytokine Growth Factor Rev 17:107–119PubMedCrossRef
26.
go back to reference Closa D, Motoo Y, Iovanna JL (2007) Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine. World J Gastroenterol 13:170–174PubMed Closa D, Motoo Y, Iovanna JL (2007) Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine. World J Gastroenterol 13:170–174PubMed
27.
go back to reference Schiesser M, Bimmler D, Frick TW, Graf R (2001) Conformational changes of pancreatitis-associated protein (PAP) activated by trypsin lead to insoluble protein aggregates. Pancreas 22:186–192PubMedCrossRef Schiesser M, Bimmler D, Frick TW, Graf R (2001) Conformational changes of pancreatitis-associated protein (PAP) activated by trypsin lead to insoluble protein aggregates. Pancreas 22:186–192PubMedCrossRef
28.
go back to reference Carter KJ, Rutledge PL, Steer ML, Silen W (1987) Secretagogue-induced changes in intracellular pH and amylase release in mouse pancreatic acini. Am J Physiol 253:G690–G696PubMed Carter KJ, Rutledge PL, Steer ML, Silen W (1987) Secretagogue-induced changes in intracellular pH and amylase release in mouse pancreatic acini. Am J Physiol 253:G690–G696PubMed
29.
go back to reference Rosendahl J, Bodeker H, Mossner J, Teich N (2007) Hereditary chronic pancreatitis. Orphanet J Rare Dis 2:1PubMedCrossRef Rosendahl J, Bodeker H, Mossner J, Teich N (2007) Hereditary chronic pancreatitis. Orphanet J Rare Dis 2:1PubMedCrossRef
30.
go back to reference Sahin-Toth M (2006) Biochemical models of hereditary pancreatitis. Endocrinol Metab Clin North Am 35:303–312PubMedCrossRef Sahin-Toth M (2006) Biochemical models of hereditary pancreatitis. Endocrinol Metab Clin North Am 35:303–312PubMedCrossRef
31.
go back to reference Teich N, Rosendahl J, Toth M, Mossner J, Sahin-Toth M (2006) Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum Mutat 27:721–730PubMedCrossRef Teich N, Rosendahl J, Toth M, Mossner J, Sahin-Toth M (2006) Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum Mutat 27:721–730PubMedCrossRef
32.
go back to reference Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D (2006) A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology 131:1844–1855PubMedCrossRef Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D (2006) A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology 131:1844–1855PubMedCrossRef
33.
go back to reference Simon P, Weiss FU, Sahin-Toth M, Parry M, Nayler O, Lenfers B, Schnekenburger J, Mayerle J, Domschke W, Lerch MM (2002) Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122→Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 277:5404–5410PubMedCrossRef Simon P, Weiss FU, Sahin-Toth M, Parry M, Nayler O, Lenfers B, Schnekenburger J, Mayerle J, Domschke W, Lerch MM (2002) Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122→Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 277:5404–5410PubMedCrossRef
34.
go back to reference Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213–216PubMedCrossRef Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213–216PubMedCrossRef
35.
go back to reference Kuwata K, Hirota M, Shimizu H, Nakae M, Nishihara S, Takimoto A, Mitsushima K, Kikuchi N, Endo K, Inoue M, Ogawa M (2002) Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroenterol 37:928–934PubMedCrossRef Kuwata K, Hirota M, Shimizu H, Nakae M, Nishihara S, Takimoto A, Mitsushima K, Kikuchi N, Endo K, Inoue M, Ogawa M (2002) Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroenterol 37:928–934PubMedCrossRef
36.
go back to reference Kiraly O, Boulling A, Witt H, Le MC, Chen JM, Rosendahl J, Battaggia C, Wartmann T, Sahin-Toth M, Ferec C (2007) Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis. Hum Mutat 28:469–476PubMedCrossRef Kiraly O, Boulling A, Witt H, Le MC, Chen JM, Rosendahl J, Battaggia C, Wartmann T, Sahin-Toth M, Ferec C (2007) Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis. Hum Mutat 28:469–476PubMedCrossRef
37.
go back to reference Boulling A, Le MC, Trouve P, Raguenes O, Chen JM, Ferec C (2007) Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet 15:936–942PubMedCrossRef Boulling A, Le MC, Trouve P, Raguenes O, Chen JM, Ferec C (2007) Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet 15:936–942PubMedCrossRef
38.
go back to reference Kiraly O, Wartmann T, Sahin-Toth M (2007) Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut 56:1434–1439CrossRef Kiraly O, Wartmann T, Sahin-Toth M (2007) Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut 56:1434–1439CrossRef
39.
go back to reference Masamune A, Kume K, Takagi Y, Kikuta K, Satoh K, Satoh A, Shimosegawa T (2007) N34S mutation in the SPINK1 gene is not associated with alternative splicing. Pancreas 34:423–428PubMedCrossRef Masamune A, Kume K, Takagi Y, Kikuta K, Satoh K, Satoh A, Shimosegawa T (2007) N34S mutation in the SPINK1 gene is not associated with alternative splicing. Pancreas 34:423–428PubMedCrossRef
40.
go back to reference Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, Rohde K, Schulz HU, Le MC, Akar N, Ammann RW, Truninger K, Bargetzi M, Bhatia E, Castellani C, Cavestro GM, Cerny M, stro-Bisol G, Spedini G, Eiberg H, Jansen JB, Koudova M, Rausova E, Macek M Jr., Malats N, Real FX, Menzel HJ, Moral P, Galavotti R, Pignatti PF, Rickards O, Spicak J, Zarnescu NO, Bock W, Gress TM, Friess H, Ockenga J, Schmidt H, Pfutzer R, Lohr M, Simon P, Weiss FU, Lerch MM, Teich N, Keim V, Berg T, Wiedenmann B, Luck W, Groneberg DA, Becker M, Keil T, Kage A, Bernardova J, Braun M, Guldner C, Halangk J, Rosendahl J, Witt U, Treiber M, Nickel R, Ferec C (2006) A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet 38:668–673PubMedCrossRef Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, Rohde K, Schulz HU, Le MC, Akar N, Ammann RW, Truninger K, Bargetzi M, Bhatia E, Castellani C, Cavestro GM, Cerny M, stro-Bisol G, Spedini G, Eiberg H, Jansen JB, Koudova M, Rausova E, Macek M Jr., Malats N, Real FX, Menzel HJ, Moral P, Galavotti R, Pignatti PF, Rickards O, Spicak J, Zarnescu NO, Bock W, Gress TM, Friess H, Ockenga J, Schmidt H, Pfutzer R, Lohr M, Simon P, Weiss FU, Lerch MM, Teich N, Keim V, Berg T, Wiedenmann B, Luck W, Groneberg DA, Becker M, Keil T, Kage A, Bernardova J, Braun M, Guldner C, Halangk J, Rosendahl J, Witt U, Treiber M, Nickel R, Ferec C (2006) A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet 38:668–673PubMedCrossRef
41.
go back to reference Morosco GJ, Goeringer GC (1979) Pancreatic elastase and serum alpha 1-antitrypsin levels in beagle dogs smoking high- and low-nicotine cigarettes: possible mechanism of pancreatic cancer in cigarette smokers. J Toxicol Environ Health 5:879–890PubMedCrossRef Morosco GJ, Goeringer GC (1979) Pancreatic elastase and serum alpha 1-antitrypsin levels in beagle dogs smoking high- and low-nicotine cigarettes: possible mechanism of pancreatic cancer in cigarette smokers. J Toxicol Environ Health 5:879–890PubMedCrossRef
42.
go back to reference Janoff A, Carp H, Lee DK, Drew RT (1979) Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Science 206:1313–1314PubMedCrossRef Janoff A, Carp H, Lee DK, Drew RT (1979) Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Science 206:1313–1314PubMedCrossRef
43.
go back to reference Evans MD, Church DF, Pryor WA (1991) Aqueous cigarette tar extracts damage human alpha-1-proteinase inhibitor. Chem Biol Interact 79:151–164PubMedCrossRef Evans MD, Church DF, Pryor WA (1991) Aqueous cigarette tar extracts damage human alpha-1-proteinase inhibitor. Chem Biol Interact 79:151–164PubMedCrossRef
44.
go back to reference Aubertin A (1991) Vitamin C: how it may protect against cancer is unclear. J Natl Cancer Inst 83:396–397PubMedCrossRef Aubertin A (1991) Vitamin C: how it may protect against cancer is unclear. J Natl Cancer Inst 83:396–397PubMedCrossRef
45.
go back to reference Pryor WA, Dooley MM, Church DF (1986) The inactivation of alpha-1-proteinase inhibitor by gas-phase cigarette smoke: protection by antioxidants and reducing species. Chem Biol Interact 57:271–283PubMedCrossRef Pryor WA, Dooley MM, Church DF (1986) The inactivation of alpha-1-proteinase inhibitor by gas-phase cigarette smoke: protection by antioxidants and reducing species. Chem Biol Interact 57:271–283PubMedCrossRef
46.
go back to reference Stockley RA, Afford SC (1983) The interaction of cigarette smoke solution with alpha 1-antitrypsin: effect on inhibitory capacity, electrophoretic mobility and immunological measurement. Clin Sci (Lond) 64:223–230 Stockley RA, Afford SC (1983) The interaction of cigarette smoke solution with alpha 1-antitrypsin: effect on inhibitory capacity, electrophoretic mobility and immunological measurement. Clin Sci (Lond) 64:223–230
47.
go back to reference Janoff A, Dearing R (1982) Alpha 1-proteinase inhibitor is more sensitive to inactivation by cigarette smoke than is leukocyte elastase. Am Rev Respir Dis 126:691–694PubMed Janoff A, Dearing R (1982) Alpha 1-proteinase inhibitor is more sensitive to inactivation by cigarette smoke than is leukocyte elastase. Am Rev Respir Dis 126:691–694PubMed
48.
go back to reference Chowdhury P, Bone RC, Louria DB, Rayford PL (1982) Effect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentration. Am Rev Respir Dis 126:177–179PubMed Chowdhury P, Bone RC, Louria DB, Rayford PL (1982) Effect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentration. Am Rev Respir Dis 126:177–179PubMed
49.
go back to reference Ito H, Watanabe T, Shore SR, Aviado DM (1976) Functional and biochemical effects on the lung following inhalation of cigarette smoke and its constituents. III. Serum antitrypsin and bronchomotor responses in rats. Toxicol Appl Pharmacol 35:403–412PubMedCrossRef Ito H, Watanabe T, Shore SR, Aviado DM (1976) Functional and biochemical effects on the lung following inhalation of cigarette smoke and its constituents. III. Serum antitrypsin and bronchomotor responses in rats. Toxicol Appl Pharmacol 35:403–412PubMedCrossRef
50.
go back to reference Majumdar AP, Davis GA, Dubick MA, Geokas MC (1985) Nicotine stimulation of protein secretion from isolated rat pancreatic acini. Am J Physiol 248:G158–G163PubMed Majumdar AP, Davis GA, Dubick MA, Geokas MC (1985) Nicotine stimulation of protein secretion from isolated rat pancreatic acini. Am J Physiol 248:G158–G163PubMed
51.
go back to reference Baskaran K, Laconi S, Reddy MK (1994) Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. Carcinogenesis 15:2461–2466PubMedCrossRef Baskaran K, Laconi S, Reddy MK (1994) Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. Carcinogenesis 15:2461–2466PubMedCrossRef
52.
go back to reference Ho YS, Chen CH, Wang YJ, Pestell RG, Albanese C, Chen RJ, Chang MC, Jeng JH, Lin SY, Liang YC, Tseng H, Lee WS, Lin JK, Chu JS, Chen LC, Lee CH, Tso WL, Lai YC, Wu CH (2005) Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 205:133–148PubMedCrossRef Ho YS, Chen CH, Wang YJ, Pestell RG, Albanese C, Chen RJ, Chang MC, Jeng JH, Lin SY, Liang YC, Tseng H, Lee WS, Lin JK, Chu JS, Chen LC, Lee CH, Tso WL, Lai YC, Wu CH (2005) Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 205:133–148PubMedCrossRef
53.
go back to reference Schuller HM, Zhang L, Weddle DL, Castonguay A, Walker K, Miller MS (2002) The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol 128:525–532PubMedCrossRef Schuller HM, Zhang L, Weddle DL, Castonguay A, Walker K, Miller MS (2002) The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol 128:525–532PubMedCrossRef
55.
go back to reference Cancela JM, Van CF, Galione A, Tepikin AV, Petersen OH (2002) Transformation of local Ca2+ spikes to global Ca2+ transients: the combinatorial roles of multiple Ca2+ releasing messengers. EMBO J 21:909–919PubMedCrossRef Cancela JM, Van CF, Galione A, Tepikin AV, Petersen OH (2002) Transformation of local Ca2+ spikes to global Ca2+ transients: the combinatorial roles of multiple Ca2+ releasing messengers. EMBO J 21:909–919PubMedCrossRef
56.
go back to reference Bragado MJ, Garcia LJ, Montero A, San Roman JI, Calvo JJ, Lopez MA (1993) Nicotinic cholinergic influences in pancreatic secretion induced by intraduodenal alkaline and acid solutions in the rabbit. Gen Pharmacol 24:687–692PubMed Bragado MJ, Garcia LJ, Montero A, San Roman JI, Calvo JJ, Lopez MA (1993) Nicotinic cholinergic influences in pancreatic secretion induced by intraduodenal alkaline and acid solutions in the rabbit. Gen Pharmacol 24:687–692PubMed
57.
go back to reference Prokopczyk B, Leder G, Trushin N, Cunningham AJ, Akerkar S, Pittman B, Ramadani M, Straeter J, Beger HG, Henne-Bruns D, El-Bayoumy K (2005) 4-Hydroxy-1-(3-pyridyl)-1-butanone, an indicator for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA damage, is not detected in human pancreatic tissue. Cancer Epidemiol Biomarkers Prev 14:540–541PubMedCrossRef Prokopczyk B, Leder G, Trushin N, Cunningham AJ, Akerkar S, Pittman B, Ramadani M, Straeter J, Beger HG, Henne-Bruns D, El-Bayoumy K (2005) 4-Hydroxy-1-(3-pyridyl)-1-butanone, an indicator for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA damage, is not detected in human pancreatic tissue. Cancer Epidemiol Biomarkers Prev 14:540–541PubMedCrossRef
58.
go back to reference Murthy SN, Dinoso VP Jr., Clearfield HR, Chey WY (1977) Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology 73:758–761PubMed Murthy SN, Dinoso VP Jr., Clearfield HR, Chey WY (1977) Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology 73:758–761PubMed
59.
go back to reference Brown P (1976) The influence of smoking on pancreatic function in man. Med J Aust 2:290–293PubMed Brown P (1976) The influence of smoking on pancreatic function in man. Med J Aust 2:290–293PubMed
60.
go back to reference Bynum TE, Solomon TE, Johnson LR, Jacobson ED (1972) Inhibition of pancreatic secretion in man by cigarette smoking. Gut 13:361–365PubMedCrossRef Bynum TE, Solomon TE, Johnson LR, Jacobson ED (1972) Inhibition of pancreatic secretion in man by cigarette smoking. Gut 13:361–365PubMedCrossRef
61.
go back to reference Askari MD, Tsao MS, Schuller HM (2005) The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol 131:639–648PubMedCrossRef Askari MD, Tsao MS, Schuller HM (2005) The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol 131:639–648PubMedCrossRef
62.
go back to reference Tai MH, Upham BL, Olson LK, Tsao MS, Reed Jr DN, Trosko JE (2007) Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells. Int J Cancer 120:1855–1862PubMedCrossRef Tai MH, Upham BL, Olson LK, Tsao MS, Reed Jr DN, Trosko JE (2007) Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells. Int J Cancer 120:1855–1862PubMedCrossRef
Metadata
Title
Cigarette smoke-induced pancreatic damage—experimental data
Authors
Uwe A. Wittel
Ulrich T. Hopt
Surinder K. Batra
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 4/2008
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-007-0273-3

Other articles of this Issue 4/2008

Langenbeck's Archives of Surgery 4/2008 Go to the issue